Joe Nocera

07/21/2014 - 1:30am

    Kalydeco is truly a wonder drug.

    Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s. It doesn't work for every sufferer of the disease but...

05/15/2014 - 4:23am

    In the United States, most of the controversy over Pfizer's $101 billion bid for AstraZeneca has been about the potential tax consequences. Pfizer pays about 27 percent of its income in corporate taxes. But if it were to succeed in taking over its British rival - and so far, at least, AstraZeneca has shown...

05/08/2014 - 9:20pm

    Mary Willingham remembers the exact moment when she realized she had to go public. It was at the memorial service in the fall of 2012 for Bill Friday, the former president of the University of North Carolina. During his long career, Friday had championed the amateur ideal - the notion that college athletes...

05/04/2014 - 11:14pm

    Jim Manzi is the founder and chairman of Applied Predictive Technologies and one of the originators of cloud computing. He is also a well-known libertarian/conservative thinker, a senior fellow at the Manhattan Institute and a contributing editor to the National Review. Between his tech background and his...

04/27/2014 - 11:37pm

    "The way to get big shots to change their behavior is to embarrass them."

    So said Warren Buffett, aka the World's Greatest Investor, in 2009 on the subject of excessive executive compensation. He was speaking at the annual meeting of his conglomerate,...

04/25/2014 - 1:32am

    This is a column about the Port Authority of New York and New Jersey, but you won't read a word in here about the lane-closing scandal in Fort Lee, N.J. This is about another scandal, one that has been going for on so long that people don't even think of it as scandalous. Indeed, it involves no...

Syndicate content